Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Trelagliptin Succinate in Type 2 Diabetes Mellitus
CTR20192019Phase 3Active
- Sponsor
- Hefei Tuorui Biotechnology
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of trelagliptin in type 2 diabetes mellitus (T2DM), sponsored by Hefei Tuorui Biotechnology. Started Nov 2019; status: active.
02
Drugs
trelagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20192019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192019.